More than $2.5 trillion in mergers were announced in the first half of 2018
[1]—
a new record. Ranked by value of the deal, energy and power deals led, followed by media and entertainment, with healthcare and industrials close behind. Industries are converging and organizations are using acquisitions, divestitures, and other forms of asset remix to reposition their businesses. For example, there are numerous mergers among pharmaceutical, life sciences, and biotech companies as they seek to gain traction in a highly fragmented market.
EY predicts that the total value of life sciences M&A will surpass $200 billion in 2018
. According to
Deloitte, technology acquisition is the primary driver of M&A pursuits, ahead of expanding customer bases in existing markets, and adding products or services
[3].
Read More